lipoma |
Disease ID | 318 |
---|---|
Disease | lipoma |
Manually Symptom | UMLS | Name(Total Manually Symptoms:13) C2585575 | recurrent abdominal pains C2127111 | fluctuating hearing loss C2112237 | posterior interosseous nerve palsy C1532393 | nuchal-type fibroma C1412297 | aicardi syndrome C0267467 | colonic intussusception C0267373 | intestinal bleeding C0235031 | neurological symptoms C0205824 | dedifferentiated liposarcoma C0158026 | monoarthritis C0031038 | pericardial cyst C0026266 | mitral incompetence C0021933 | intussusception |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:5) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:1) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121913529 | 25928347 | 3845 | KRAS | umls:C0023798 | BeFree | We conclude that KENS, the intraneural Schwann cell proliferation and the lipoma in this individual were caused by a postzygotic and mosaic activating c.35G > A (p.Gly12Asp) KRAS mutation. | 0.000271442 | 2015 | KRAS | 12 | 25245350 | C | T,G,A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:1) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0023798 | hydromorphone | D004091 | 466-99-9 | lipoma | MESH:D008067 | marker/mechanism | 24141031 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |